Fei Liu
- Cancer Research top 0.5%
- MicroRNA in disease regulation 46
- Cancer-related molecular mechanisms research 24
- Cancer, Hypoxia, and Metabolism 20
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation 21
- RNA modifications and cancer 19
- Nephrology top 1%
- Renal Diseases and Glomerulopathies 27
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 25
- Immunology top 1%
-
- Autophagy in Disease and Therapy 20
- Co-authors
- Inge Grundke‐IqbalDaniel J. TschumperlinKhalid IqbalCheng-Xin GongGerald W. HartInder M. VermaAndrew M. TagerBarry S. Shea
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fei Liu
719 papers receiving 16.3k citations
Hit Papers
Peers
Comparison fields: 5 of 204
- Cancer Research 2.2k
- Molecular Biology 6.2k
- Nephrology 635
- Hepatology 678
- Immunology 1.8k
Countries citing papers authored by Fei Liu
This map shows the geographic impact of Fei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Liu more than expected).
Fields of papers citing papers by Fei Liu
This network shows the impact of papers produced by Fei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Liu. The network helps show where Fei Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fei Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 21 | |
| 8 | 2023 | 16 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 19 | |
| 11 | Predicting New-Onset Postoperative Atrial Fibrillation Following Isolated Coronary Artery Bypass Grafting: Development and Validation of a Novel Nomogram | 2022 | 11 |
| 12 | Biomechanical Effects of Pedicle Screw Positioning on the Surgical Segment in Models After Oblique Lumbar Interbody Fusion: An in-silico Study | 2022 | 11 |
| 13 | 2021 | 15 | |
| 14 | 2019 | 23 | |
| 15 | 2019 | 4 | |
| 16 | 2018 | 8 | |
| 17 | 2014 | 29 | |
| 18 | 2012 | 337 | |
| 19 | 2010 | 14 | |
| 20 | O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's diseasebreakdown → | 2004 | 616 |
About Fei Liu
Fei Liu is a scholar working on Cancer Research, Nephrology, Hepatology, Pathology and Forensic Medicine and Oncology, having authored 763 papers that have together received 16.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (46 papers), Renal Diseases and Glomerulopathies (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Cancer-related molecular mechanisms research (24 papers), Epigenetics and DNA Methylation (21 papers), Cancer, Hypoxia, and Metabolism (20 papers), Autophagy in Disease and Therapy (20 papers) and RNA modifications and cancer (19 papers). The work is most often cited by research in Cancer Research (2.2k citations), Molecular Biology (6.2k citations), Nephrology (635 citations), Hepatology (678 citations) and Immunology (1.8k citations). Fei Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Inge Grundke‐Iqbal, Daniel J. Tschumperlin, Khalid Iqbal, Cheng-Xin Gong, Gerald W. Hart, Inder M. Verma, Andrew M. Tager, Barry S. Shea, Justin D. Mih and Asma Sharif. Their work appears in journals such as Medicine, Frontiers in Pharmacology, PLoS ONE, International Journal of Biological Macromolecules and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.